$15.45 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest



Cytek Biosciences, Inc is a cell analysis solutions company. The Company offers cell analysis tools by leveraging technical approaches. Its instruments, the Aurora and Northern Lights systems, are the spectrum flow cytometers able to deliver cell analysis by utilizing the spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells Full Spectrum Profiling (FSP). Its FSP technology optimizes through its optical and electronic designs that utilize a method of light detection and distribution. Its FSP platform includes instruments, reagents, software and services to provide a suite of solutions for its customers. Its FSP platform addresses the limitations of other technologies by providing a density of information for performance. Its patented FSP technology is designed to optimize through its optical and electronic designs that utilizes a method of light detection and distribution to a selected number of detectors of a particular type.

Stock Analysis

last close $14.69
1-mo return 30.9%
3-mo return 87.9%
avg daily vol. 473.9T
52-week high 28.7
52-week low 7.38
market cap. $2.0B
forward pe 190.8
annual div. -
roe 0.45%
ltg forecast -
dividend yield -
annual rev. $139M
inst own. 43.5%

Subscribe now for daily local and international financial news